BRCA2 and breast cancer: Germline mutations in BRCA1 account for about 3% of all breast cancers, with a further 2% resulting from mutations in BRCA2. Breast cancer patients with mutated BRCA1 frequently demonstrate loss of the corresponding wild-type allele (Cornelis et al, 1995).